MaxCyte, Inc. (MXCT) Stock Overview
Explore MaxCyte, Inc.’s financial performance, market position, analyst ratings, and future outlook.
MaxCyte, Inc. (MXCT)
Key Financials
Key Financials
Market Cap
122.1M
P/E Ratio
-3.17
EPS (TTM)
$-0.36
ROE
-0.22%
MXCT Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of MaxCyte, Inc. (MXCT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 60.69, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.17 and a market capitalization of 122.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.